2 news items
Mustang Bio Expands CAR T-Cell Therapy Platform Expansion Into Autoimmune Diseases
MBIO
28 Mar 24
Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
FBIO
MBIO
28 Mar 24
-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is underway and expected
- Prev
- 1
- Next